Frazier Life Sciences invests in and builds companies developing and commercializing novel therapeutics at all stages.
Frazier Life Sciences invests in and builds companies developing and commercializing novel therapeutics at all stages, from company formation to public.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 14, 2022
Alpha9 Theranostics
|
Series B | $75M | Biotechnology | — |
Nov 14, 2022
MBX Biosciences
|
Series B | $115M | Biotechnology | — |
May 9, 2022
Aspen Neuroscience
|
Series B | $147.50M | Biotechnology | — |